Lipid testing

• less useful with increasing age

• naturally increase until approx. 65yo and begin to decline in most

• no clear optiaml level aged >80

• low lipid may be indicator of poor nutritional status

  • occult disease

  • increase risk of underlying moriditiy and mortality

• continued lipid testing with normal baseline unneccesasry

• statin not normally initiated

• role for follow-up who are being treated with a statin for 2ary prevention

• once goal = q3yrs

Statin use

• uncertain

• young elderly

  • some evidence of benefit

• vs very elderly

  • no evidence reduces mortality

  • all-cause mortality highest when total cholesterol \<5.5

• secondary prevention

  • reduces all cause mortality

  • reduces incidence of cardiovascalur events